of cochlear implants. Conclusions: Despite the risk of electrical interference between implanted medical devices, DBS and cochlear implants may be safe and compatible in the same patient if necessary precautions are taken.
ment electrical interference from the cochlear device on microelectrode recordings during STN DBS implantation and discuss modifications in surgical technique.
Clinical Presentation

Patient Background
A 70-year-old male with idiopathic PD for over a decade and bilateral severe to profound sensorineural hearing loss presented for DBS surgery. The patient's hearing loss was secondary to viral meningitis in 2006 and managed with bilateral cochlear implants. He reported significant benefit from the cochlear implants and denied side effects such as tinnitus, vertigo, or imbalance.
Despite maximum medical therapy, motor fluctuations with rigidity and gait initiation dysfunction became progressively worse. With demonstrated responsiveness to levodopa (UPDRS III 34 to 11; doubled gait speed) and after neuropsychological evaluation revealed no contraindications, DBS surgery was recommended.
Microelectrode-Guided Bilateral STN DBS Implantation
Two months prior to DBS surgery, the patient's cochlear implant magnets were removed in order to obtain a preoperative MRI (Siemens Avanto 1.5 T, T2-weighted turbo spin-echo and fast gray matter acquisition T1 inversion recovery sequences) for surgical planning. The magnets were replaced the same day following MRI. In spite of magnet removal, there was significant artifact that made targeting STN more favorable than globus pallidus internus ( fig. 1 ) .
The patient underwent frame-based, stereotactic microelectrode-guided insertion of DBS leads (Medtronic Inc., Minneapolis, Minn., USA, 3389S-40) into STN bilaterally. After frame place- While undergoing intraoperative test macrostimulation, the patient's left cochlear implant was reactivated, so the patient could hear and interact with the surgical team. Right STN intraoperative test stimulation yielded transient paresthesias in the left hand and forearm without corticospinal activation. Left STN intraoperative test stimulation suppressed the patient's right leg tremor. After satisfactory macrostimulation testing, the electrodes were anchored and their position was confirmed with fluoroscopy. On postoperative day 1, the patient was discharged home after CT imaging. DBS electrode positions were verified by fusing the postoperative CT images with the preoperative MRI ( fig. 3 ) . The implanted pulse generator was placed during a second-stage operation 3 weeks later. Care was taken to tunnel the lead extensions posterior to the cochlear implant internal receiver.
Postoperative Outcome At 4 months, the patient reported improvement in PD symptoms with the following DBS settings: both left and right DBS were set to unipolar configuration with amplitude 1.2 V, pulse width 60 μs, and frequency 140 Hz. The patient decreased his levodopa requirement by almost 50%.
Since the DBS surgery, the patient continued to report benefit from his Nucleus Freedom cochlear implants (Cochlear Corp., Sydney, N.S.W., Australia). He denied change in his hearing. No distorted sounds were heard in either ear. His device settings have remained unchanged. Even though the manufacturer (Cochlear Corp.) warns of neurostimulation in the physician packet insert: 'Do not use neurostimulation directly over the cochlear implant. High currents induced into the electrode lead can cause tissue damage to the cochlea or permanent damage to the implant' [2] , the patient did not report adverse effects from the device.
Discussion and Literature Review
As technology advances, an increasing number of PD patients considering DBS will also have preexisting implanted electrical devices. Before implanting DBS electrodes, clinicians should be aware of the risk for electromagnetic interference between implanted electrical devices. Medtronic Inc. reports possible device interactions between DBS systems and cardiac pacemakers, implant- able defibrillators, cochlear implants, and other active implanted devices in their prescriber manual [3] . Serious complications have occurred after exposure of DBS systems to high-energy electromagnetic fields. Nutt et al. [4] report the case of a PD patient who suffered permanent diencephalic and brainstem lesions after receiving microwave diathermy near his STN DBS lead during a dental procedure. The authors concluded that the diathermy induced a radiofrequency current, which heated the electrodes and destroyed nearby CNS tissue. The patient was left in a vegetative state. In another case report, Yamamoto et al. [5] describe a patient who suffered an unexpected thalamotomy near his implanted DBS after cardioversion. The patient had a radiofrequency-coupled DBS system. During cardioversion, the patient's radiofrequency receiver transmitted the external cardioversion current, causing the thalamotomy.
In spite of these risks, DBS and other electromagnetic devices have been successfully implanted into the same patient [6, 7] . In our patient, there were no adverse effects that would suggest electrical interference between his cochlear implants and STN DBS electrodes. This may be because of the distance between the devices and their relatively low, localized amount of electrical stimulation. Other cases of patients having successful implantation of both DBS and cochlear implants have been reported using different techniques ( table 1 ) .
St. Martin and Hirsch [8] reported a PD patient with DBS who later underwent cochlear device implantation for severe sensorineural hearing loss.
De Los Reyes et al. [9] reported a patient with a unilateral cochlear implant and essential tremor that required contralateral thalamic DBS. Even though the cochlear implant magnet was removed to obtain preoperative MRI, the study was contaminated with artifact and required CT targeting. Details of microelectrode recording were not provided.
Cif et al. [10] reported an 8-year-old boy with MohrTranebjaerg syndrome (deafness, dystonia, optic neuropathy) and a unilateral cochlear implant. The cochlear device was removed preoperatively and reimplanted 8 months after DBS surgery. There was no device interference and the patient's dystonia dramatically improved with DBS. Based on our experience and after literature review, we found that there are several necessary technique modifications in order to perform successful DBS surgery in patients with preexisting cochlear implants. First, it is imperative that the DBS clinicians work together with the patient's otologist in order to coordinate magnet removal/replacement for a preoperative MRI. Despite magnet removal, there still may be significant artifact from the cochlear device and thus CT may be used for targeting purposes. Postoperatively, MRI may not be possible for lead localization if the magnets have been replaced, and so instead, CT must suffice.
Second, avoid damaging the preexisting cochlear implants when tunneling DBS lead extensions past the cochlear device's internal receiver. We used fluoroscopy to safely identify and avoid the internal receiver.
Finally, intraoperative patient communication may require a functional cochlear implant, so we recommend replacing the magnets prior to DBS surgery. Even though an activated cochlear implant will interfere with microelectrode recordings, it can be temporarily deactivated during surgery. After satisfactory DBS lead placement, the cochlear implant can be reactivated to facilitate patient-to-surgeon communication for intraoperative stimulation testing.
Conclusions
Subthalamic DBS can be successfully performed in PD patients with preexisting cochlear implants. Preexisting cochlear implants should not be regarded as a contraindication to DBS as the magnet can be easily removed and replaced in the outpatient setting for MR imaging, and electrical interference during microelectrode recordings can be mitigated by turning off the implant.
